Management of Diabetic Ketoacidosis in Adults: A Narrative Review
- PMID: 32952507
- PMCID: PMC7485658
- DOI: 10.4103/sjmms.sjmms_478_19
Management of Diabetic Ketoacidosis in Adults: A Narrative Review
Abstract
Diabetic ketoacidosis (DKA) is the most common hyperglycemic emergency and causes the greatest risk for death in patients with diabetes mellitus. DKA more commonly occurs among those with type 1 diabetes, yet almost a third of the cases occur among those with type 2 diabetes. Although mortality rates from DKA have declined to low levels in general, it continues to be high in many developing countries. DKA is characterized by hyperglycemia, metabolic acidosis and ketosis. Proper management of DKA requires hospitalization for aggressive intravenous fluids, insulin therapy, electrolyte replacement as well as identification and treatment of the underlying precipitating event along with frequent monitoring of patient's clinical and laboratory states. The most common precipitating causes for DKA include infections, new diagnosis of diabetes and nonadherence to insulin therapy. Clinicians should be aware of the occurrence of DKA in patients prescribed sodium-glucose co-transporter 2 inhibitors. Discharge plans should include appropriate choice and dosing of insulin regimens and interventions to prevent recurrence of DKA. Future episodes of DKA can be reduced through patient education programs focusing on adherence to insulin and self-care guidelines during illness and improved access to medical providers. New approaches such as extended availability of phone services, use of telemedicine and utilization of public campaigns can provide further support for the prevention of DKA.
Keywords: Diabetes mellitus; fluid management; insulin; ketoacidosis.
Copyright: © 2020 Saudi Journal of Medicine & Medical Sciences.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Diabetic ketoacidosis: risk factors and management strategies.Treat Endocrinol. 2003;2(2):95-108. doi: 10.2165/00024677-200302020-00003. Treat Endocrinol. 2003. PMID: 15871546 Review.
-
Comprehensive review of diabetic ketoacidosis: an update.Ann Med Surg (Lond). 2023 May 23;85(6):2802-2807. doi: 10.1097/MS9.0000000000000894. eCollection 2023 Jun. Ann Med Surg (Lond). 2023. PMID: 37363479 Free PMC article.
-
Treatment Challenges and Controversies in the Management of Critically Ill Diabetic Ketoacidosis (DKA) Patients in Intensive Care Units.Cureus. 2024 Sep 6;16(9):e68785. doi: 10.7759/cureus.68785. eCollection 2024 Sep. Cureus. 2024. PMID: 39360087 Free PMC article. Review.
-
Evaluation and Management of the Critically Ill Adult With Diabetic Ketoacidosis.J Emerg Med. 2020 Sep;59(3):371-383. doi: 10.1016/j.jemermed.2020.06.059. Epub 2020 Aug 4. J Emerg Med. 2020. PMID: 32763063 Review.
-
Management of decompensated diabetes. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome.Crit Care Clin. 2001 Jan;17(1):75-106. doi: 10.1016/s0749-0704(05)70153-6. Crit Care Clin. 2001. PMID: 11219236 Review.
Cited by
-
Efficacy and Safety of Intravenous Insulin in Treatment of Patient With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis.Cureus. 2022 Oct 26;14(10):e30721. doi: 10.7759/cureus.30721. eCollection 2022 Oct. Cureus. 2022. PMID: 36439560 Free PMC article. Review.
-
Abdominal Pain Mimics.Emerg Med Clin North Am. 2021 Nov;39(4):839-850. doi: 10.1016/j.emc.2021.07.003. Epub 2021 Sep 10. Emerg Med Clin North Am. 2021. PMID: 34600641 Free PMC article. Review.
-
A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors.Int J Mol Sci. 2023 Apr 21;24(8):7630. doi: 10.3390/ijms24087630. Int J Mol Sci. 2023. PMID: 37108792 Free PMC article. Review.
-
A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.Cureus. 2023 Sep 13;15(9):e45180. doi: 10.7759/cureus.45180. eCollection 2023 Sep. Cureus. 2023. PMID: 37842482 Free PMC article.
-
A Case of Diabetic Ketoacidosis With Persistent Alkalosis.Cureus. 2025 Mar 12;17(3):e80470. doi: 10.7759/cureus.80470. eCollection 2025 Mar. Cureus. 2025. PMID: 40225507 Free PMC article.
References
-
- Große J, Hornstein H, Manuwald U, Kugler J, Glauche I, Rothe U. Incidence of diabetic ketoacidosis of new-onset type 1 diabetes in children and adolescents in different countries correlates with human development index (HDI): An updated systematic review, meta-analysis, and meta-regression. Horm Metab Res. 2018;50:209–22. - PubMed
-
- Fredheim S, Johannesen J, Johansen A, Lyngsøe L, Rida H, Andersen ML, et al. Danish Society for Diabetes in Childhood and Adolescence. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels. Diabetologia. 2013;56:995–1003. - PubMed